Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia

被引:0
|
作者
Mendez, Raul [1 ,2 ,3 ,4 ]
Gonzalez-Jimenez, Paula [1 ,2 ,3 ]
Mengot, Noe [1 ,2 ]
Menendez, Rosario [1 ,2 ,3 ,4 ,5 ]
机构
[1] La Fe Univ & Polytech Hosp, Pneumol Dept, Valencia, Spain
[2] Hlth Res Inst La Fe IISLAFE, Resp Infect, Valencia, Spain
[3] Univ Valencia, Dept Med, Valencia, Spain
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain
[5] Hosp Univ & Politecn La Fe, Serv Neumol, Avda Fernando Abril Martorell 106, Valencia 46026, Spain
关键词
CAP; inflammatory-immune response; microbiologic treatment; RESPIRATORY-DISTRESS-SYNDROME; INFECTIOUS-DISEASES-SOCIETY; LENGTH-OF-STAY; HOSPITALIZED-PATIENTS; ANTIBIOTIC-TREATMENT; THORACIC-SOCIETY; RISK-FACTORS; EARLY SWITCH; TIME; OUTCOMES;
D O I
10.1055/s-0043-1778139
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Treatment failure and clinical stability are important outcomes in community-acquired pneumonia (CAP). It is essential to know the causes and risk factors for treatment failure and delay in reaching clinical stability in CAP. The study of both as well as the associated underlying mechanisms and host response are key to improving outcomes in pneumonia.
引用
收藏
页码:225 / 236
页数:12
相关论文
共 50 条
  • [11] Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia
    Hoogewerf, M.
    Oosterheert, J. J.
    Hak, E.
    Hoepelman, I. M.
    Bonten, M. J. M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (11) : 1097 - 1104
  • [12] Severe Community-Acquired Pneumonia
    Sligl, Wendy I.
    Marrie, Thomas J.
    CRITICAL CARE CLINICS, 2013, 29 (03) : 563 - +
  • [13] Early prediction of treatment failure in severe community-acquired pneumonia: The PRoFeSs score
    Pereira, Jose Manuel
    Laszczynska, Olga
    Azevedo, Ana
    Basilio, Carla
    Sousa-Dias, Conceicao
    Mergulhao, Paulo
    Paiva, Jose Artur
    JOURNAL OF CRITICAL CARE, 2019, 53 : 38 - 45
  • [14] Definition, Epidemiology, and Pathogenesis of Severe Community-Acquired Pneumonia
    Cavallazzi, Rodrigo
    Ramirez, Julio A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (02) : 143 - 157
  • [15] Choosing antibiotic therapy for severe community-acquired pneumonia
    Martin-Loeches, Ignacio
    Garduno, Alexis
    Povoa, Pedro
    Nseir, Saad
    CURRENT OPINION IN INFECTIOUS DISEASES, 2022, 35 (02) : 133 - 139
  • [16] Community-Acquired Pneumonia
    File, Thomas M., Jr.
    Ramirez, Julio A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (07) : 632 - 641
  • [17] An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia
    Akram, A. R.
    Chalmers, J. D.
    Taylor, J. K.
    Rutherford, J.
    Singanayagam, A.
    Hill, A. T.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (12) : 1174 - 1180
  • [18] Severe community-acquired pneumonia compared to severe community-acquired Acinetobacter baumannii pneumonia in Reunion Island: A retrospective study
    Rotini, Giacomo
    de Mangou, Axel
    Combe, Agathe
    Renou, Amelie
    Combe, Chloe
    Cally, Radj
    Lagrange-Xelot, Marie
    Allou, Nicolas
    Miltgen, Guillaume
    Vidal, Charles
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2025, 30 (01) : 43 - 50
  • [19] Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
    Aliberti, Stefano
    Brambilla, Anna Maria
    Chalmers, James D.
    Cilloniz, Catia
    Ramirez, Julio
    Bignamini, Angelo
    Prina, Elena
    Polverino, Eva
    Tarsia, Paolo
    Pesci, Alberto
    Torres, Antoni
    Blasi, Francesco
    Cosentini, Roberto
    RESPIRATORY RESEARCH, 2014, 15
  • [20] Clinical Approach to Community-acquired Pneumonia
    Cilloniz, Catia
    Rodriguez-Hurtado, Diana
    Nicolini, Antonello
    Torres, Antoni
    JOURNAL OF THORACIC IMAGING, 2018, 33 (05) : 273 - 281